On December 22 JSC Olainfarm organized its third quarter 2015 Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of third quarter 2015 and informed about the company’s future activities, this time paying extra attention to JSC Olainfarm daughter company Silvanols Ltd..

The recorded Olainfarm webinar is available online: ej.uz/OLF_3Q2015_video, and the presentation, demonstrated during the webinar, can be found in the previously published company’s announcement:https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=690522&messageId=862500.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
e-mail: Salvis.Lapins@olainfarm.lv